Testosterone Lawsuit News Website Launched By Hissey Kientz, LLP Law Firm
Austin, Texas (PRWEB) March 13, 2014 -- The law firm of Hissey Kientz, LLP is announcing the launch of its new website, Testosterone Lawsuit News (http://www.testosteronelawsuitnews.com). The site will serve as a source for news and legal information for patients and their families who have experienced complications such as heart attack, stroke, pulmonary embolism or coronary artery disease after taking testosterone boosting drugs.
In November 2013, a Journal of the American Medical Association (JAMA) study linked testosterone booster drugs to an increased risk of heart attack and stroke. The study reported that men who used testosterone drugs were 30 percent more likely to have a heart attack, stroke, or to die during a three-year period than men with low hormone levels who didn’t take the supplements.*
Low testosterone drugs were approved by the FDA to treat men diagnosed with low testosterone levels. The number of prescriptions has risen to 432 million, including refills, in 2013 from 208 million in 2008. **
According to the JAMA study, testosterone boosters were approved by the FDA to treat men diagnosed with hypogonadism, an endocrine disorder that usually results in severe testosterone deficiency. However, nearly a quarter of men who receive a prescription for testosterone therapy drugs have not had necessary blood tests to diagnose hypogonadism.*
On Jan. 31, 2014, the U.S. Food and Drug Administration (FDA) announced it would investigate the risk of heart attack, stroke and death in men using prescription testosterone products.***
Patients who have experienced a heart attack, stroke, pulmonary embolism or other serious side effects from testosterone therapy drugs may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com
*media.jamanetwork.com/news-item/testosterone-therapy-following-coronary-angiography-associated-increased-risk-adverse-outcomes/
**http://online.wsj.com/news/articles/SB10001424052702303661404579180294201174958
About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents individuals affected by testosterone booster side effects, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, and Effexor, problems with transvaginal mesh, DePuy ASR, Stryker, and Biomet hip replacements, Mirena IUDs, GranuFlo dialysis concentrate and other defective drugs and medical devices.
Allison Sass, Hissey Kientz LLP, +1 (866) 275-4454, [email protected]
Share this article